New Light-Activated cancer injection enters human testing
NCT ID NCT04389281
Summary
This is an early-stage safety study testing a new treatment called X-PACT for people with advanced solid tumors that have spread or returned. The treatment involves injecting a drug and a special material directly into a tumor, then applying X-ray energy to activate it. The main goal is to see if this approach is safe and to find the right dose, while also checking if it helps control the tumor's growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Duke University
RECRUITINGDurham, North Carolina, 27710, United States
Contact
Contact
-
Levine Cancer Institute
RECRUITINGCharlotte, North Carolina, 28204, United States
Contact
Contact
-
Prisma Health
RECRUITINGGreenville, South Carolina, 29605, United States
Contact
-
Sibley Hospital - Johns Hopkins University
RECRUITINGWashington D.C., District of Columbia, 20016, United States
Contact
Conditions
Explore the condition pages connected to this study.